Michelle Doig

Michelle Doig

Michelle Doig has over 20 years’ experience working with life sciences companies at leading International Venture Capital and Investment Banking Firms. She joined Omega Funds in December 2016, as a Partner and Head of Corporate Development. Prior to that, she was...
Chen Yu

Chen Yu

Dr. Yu is the founder and Managing Partner at TCG X. Prior to founding TCG X, Dr. Yu was a Managing Partner for seventeen years at Vivo Capital where he pioneered the firm’s efforts in cross border investments between the US and China.   Dr. Yu has extensive operating...
Mark Chin

Mark Chin

Mark is an experienced venture capital investor, with significant experience as a board director of both private and public biotech companies in the US and Europe. He is currently a managing director at Arix Bioscience and a board director of Harpoon Therapeutics...
Mike Ross

Mike Ross

Mike Ross’ career spans over 15 years in venture capital, which followed 21 years in senior operating executive roles for leading biotechnology companies.  He joined SV Health Investors as a Venture Partner in 2001 and became a Managing Partner in 2002. Mike was the...
Beat Steffen

Beat Steffen

Dr. Beat Steffen is a Principal at NVF in Basel, Switzerland. Prior to joining NVF, he worked at Novartis Pharmaceuticals in commercial roles in the US and in Switzerland launching several products mainly in the cardiovascular area. Beat joined Novartis from...